SCHEMBL15859415

SCHEMBL15859415

CC1=C(OC(=O)Nc2ccccc2C)C(c2ccc([N+](=O)[O-])cc2)C2=C(CCCC2=O)N1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 19/20 0.59
KDM4E B2RXH2 1/20 0.50
GPR174 Q9BXC1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15859363 0.91 FFAR3 (0.57) FFAR3KDM4E
SCHEMBL15859396 0.86 FFAR3 (0.62) FFAR3KDM4EGPR174
SCHEMBL15859429 0.86 FFAR3 (0.61) FFAR3KDM4E
SCHEMBL5064697 0.86 FFAR3 (0.79) FFAR3KDM4E
SCHEMBL15859398 0.83 FFAR3 (0.75) FFAR3KDM4E
SCHEMBL15859458 0.81 FFAR3 (0.56) FFAR3KDM4E
SCHEMBL15859333 0.80 FFAR3 (0.74) FFAR3KDM4E
SCHEMBL5061501 0.77 FFAR3 (0.75) FFAR3KDM4E
SCHEMBL5238694 0.76 GPR174 (0.57) FFAR3KDM4EGPR174
SCHEMBL3263109 0.73 FFAR3 (0.84) FFAR3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812080-B1 GPR41 AND MODULATORS THEREOF FOR THE TREATMENT OF INSULIN-RELATED DISORDERS ARENA PHARM INC (US) 2014-07-09 EP claimed